Medbanks
PublicMedbanks is now publicly traded
The data on this page reflects Medbanks's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Dec 23, 2022
Last Round
Series F
Jun 1, 2021
Est. Valuation at Exit
$1.72B
Total Funding Raised
$645.49M
Company Overview
Medbanks (HKG: 00314) is a medical technology and health management company that operates specialty pharmacy stores, provides site management services for clinical trials, and offers insurance brokerage services in China.
Sector
Healthcare/Wellness
AI Layer
Application
Keywords
Medbanks Comparables
Compare Medbanks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Miaoshou Doctor | 76% |
Medbanks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Dec 23, 2022 | ||||
| Series F | Jun 1, 2021 | ||||
| Series E | Dec 21, 2020 | ||||
| Series D Extension | Nov 20, 2019 | ||||
| Series D | Jan 9, 2019 | ||||
Series C | Apr 16, 2018 |
Medbanks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series D |
| IDG Capital | Series D, IPO, Series D Extension, Series C |
| China International Capital Corporation | Series D Extension, Series D |
| Jeneration Capital | Series E |
| Wu Capital | Series D Extension |
| F-Prime Capital | Series B, Series D, IPO, Series A, Series D Extension |
| Eight Roads Ventures | Series B, Series D, IPO, Series A, Series D Extension |
Medbanks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access